Evaluation of thyroid dysfunction as a candidate surrogate marker for efficacy of sunitinib in patients (pts) with advanced renal cell cancer (RCC)

被引：13
|
作者：
Wolter, P.
Stefan, C.
Decallonne, B.
Dumez, H.
Fieuws, S.
Wildiers, H.
Clement, P.
Debaere, D.
Van Oosterom, A.
Schoffski, P.
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] Catholic Univ Louvain, B-3000 Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5126
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Thyroid function test (TFT) abnormalities in patients (pts) with metastatic renal cell carcinoma (RCC) treated with sorafenib
    Tamaskar, I. R.
    Unnithan, J.
    Garcia, J. A.
    Dreicer, R.
    Wood, L.
    Iochimescu, A.
    Bukowski, R.
    Rini, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] A phase 1/2 study to evaluate the efficacy and safety of HB0025 monotherapy for patients (pts) with advanced renal cell carcinoma (RCC)
    Qu, Yuan-Yuan
    Ye, Dingwei
    Bian, Xiaojie
    Han, Weiqing
    Liu, Kan
    Dai, Tao
    Sun, Yuping
    Bian, Jiasheng
    Dang, Qi
    Sun, Meili
    Wang, Zhen
    Zhang, Jian
    Zhou, Huan
    Gao, Zhenyuan
    Zhu, Xiangyang
    Yang, Yongmin
    Chen, Juan
    Yang, Yang
    Wang, Junning
    Cai, Ye
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] PET/CT assessment of tumor perfusion (TP) in metastatic renal cell cancer (RCC) patients (pts) on sunitinib (S) using 62Cu-ETS
    Logan, Theodore F.
    Fletcher, James W.
    Green, Mark A.
    Eitel, Jacob Aaron
    Althouse, Sandra K.
    Perkins, Susan M.
    Hutchins, Gary
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Phase II trial of linifanib in patients (pts) with advanced renal cell carcinoma (RCC): Analysis of pts receiving extended therapy.
    Posadas, E. M.
    Tannir, N. M.
    Wong, Y.
    Ernstoff, M. S.
    Kollmannsberger, C. K.
    Qian, J.
    Ansell, P. J.
    McKeegan, E. M.
    Mckee, M. D.
    Ricker, J. L.
    Carlson, D. M.
    Michaelson, M. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [45] Patterns of treatment (trx) and safety of angiogenesis inhibitors in patients (pts) with advanced renal cell carcinoma (RCC) in France
    Gross-Goupil, M.
    Oudard, S.
    Levy, A.
    Elaidi, R.
    Scotte, F.
    Duh, M. S.
    Sarda, S. P.
    Korves, C.
    Goglia, R.
    Ramamurthy, P.
    Neary, M.
    Escudier, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] Safety and efficacy of axitinib (axi) in combination with pembrolizumab (pembro) in patients (pts) with advanced renal cell cancer (aRCC).
    Atkins, Michael B.
    Plimack, Elizabeth R.
    Puzanov, Igor
    Fishman, Mayer N.
    McDermott, David F.
    Cho, Daniel C.
    Vaishampayan, Ulka N.
    George, Saby
    Olencki, Thomas
    Tarazi, Jamal Christo
    Rosbrook, Brad
    Fernandez, Kathrine C.
    Lechuga, Mariajose
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] Treatment (tx) Patterns and Toxicity of Angiogenesis Inhibitors in Patients (pts) With Advanced Renal Cell Carcinoma (RCC) in Spain
    Castellano, D.
    Duh, M. S.
    Suthoff, E. Dial
    Korves, C.
    Vekeman, F.
    Ramamurthy, P.
    Mykletun, A.
    Lyon-Caen, S.
    Neary, M. P.
    Bellmunt, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S514 - S515
  • [48] Sequential axitinib (AG-013736) therapy of patients (pts) with metastatic clear cell renal cell cancer (RCC) refractory to sunitinib and sorafenib, cytokines and sorafenib, or sorafenib alone
    Dutcher, J. P.
    Wilding, G.
    Hudes, G. R.
    Stadler, W. M.
    Kim, S.
    Tarazi, J. C.
    Rosbrook, B.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer
    Grundbichler, Michael
    Mlineritsch, Brigitte
    Ressler, Sigrun
    Moik, Martin
    Kappacher, Andrea
    Rosenlechner, Sabine
    Greil, Richard
    ONCOLOGY, 2011, 80 (1-2) : 34 - 41
  • [50] Phase II efficacy and safety study of nintedanib versus sunitinib in previously untreated renal cell carcinoma (RCC) patients
    Eisen, Tim
    Shparyk, Yaroslav
    Jones, Robert
    MacLeod, Nicholas James
    Temple, Graham
    Finnigan, Helen
    Kaiser, Rolf
    Studeny, Matus
    Loembe, Arsene Bienvenu
    Bondarenko, Igor
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345